Study to Evaluate the Efficacy and Safety of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) and Inadequate Response to Ursodeoxycholic Acid

Northwell Health Institution, Manhasset

University of Virginia, Charlottesville

Virginia Commonwealth University, Richmond

Asheville Gastroenterology Associates, Asheville

Piedmont Research Institute, Atlanta

Schiff Center for Liver Diseases, Miami

Cleveland Clinic Florida, Weston

Clinic for Gastroenterology and Hepatology, Cologne

Johannes Gutenberg University, Mainz

University Hospital Frankfurt, Frankfurt

Hopital Saint-Antoine, Paris

UT Southwestern Medical Center, Dallas

Baylor College of Medicine, Houston

Mayo Clinic in Arizona, Phoenix

Swedish Medical Center, Seattle

Massachusetts General Hospital, Boston

Beth Israel Deaconess Medical Center, Boston

Liver Unit, University of Barcelona, Barcelona

Hospital De La Sant Creu St. Pau, Barcelona

University of Birmingham Centre for Liver Research, Birmingham

Addenbrooke's Hospital, Cambridge

The Royal Liverpool University Hospital, Liverpool

King's College Hospital, London

The Newcastle Upon Tyne Hosptials NHS Foundation Trust, Newcastle upon Tyne